Approaches to Recurrent Gastroesophageal Reflux After Fundoplication

When antireflux surgery is performed for refractory gastroesophageal reflux disease, most patients experience durable relief. A small but meaningful subset, however, return to clinic months or years later with heartburn, regurgitation, dysphagia, or atypical symptoms that mimic their original presentation. This pattern, broadly labelled recurrent reflux after fundoplication, has become a familiar referral to upper gastrointestinal surgeons across Australia and New Zealand.

Estimates from international cohorts suggest that 8–15% of patients undergoing primary repair will eventually require reintervention, and a larger proportion will restart acid-suppressing medication at some point. In Australian practice, where public hospital waiting lists, private insurance arrangements, and the structure of the Medicare Benefits Schedule all shape the patient's journey, the question is not simply whether to revise the wrap but when, how, and by whom.

The following review summarises the mechanisms behind a failed fundoplication, the diagnostic pathway used by Australian subspecialists, the role of non-operative therapy, and the surgical options currently available for revision. It is intended for surgeons, gastroenterologists, and advanced trainees who participate in multidisciplinary oesophageal clinics in Sydney, Melbourne, and Brisbane.

Why fundoplications fail

Wrap failure follows a limited set of anatomical patterns, and recognising the dominant mechanism is the first step in planning revision. The most frequent cause is disruption of the crural repair or migration of the wrap into the chest, producing a recurrent hiatal hernia. A slipped Nissen, where the body of the stomach migrates cephalad through the fundoplication, produces a similar picture but is recognised intra-operatively by the position of the gastro-oesophageal junction.

The opposite problem, an over-tight or over-long wrap, tends to present earlier with dysphagia, gas-bloat, and inability to belch rather than with classic reflux. Telescoping of the wrap, transdiaphragmatic adhesion formation, and primary motility deterioration account for most remaining recurrences. Pre-operative documentation of the original operative note is invaluable, because the index technique, partial versus 360-degree, dictates the safest revisional approach.

Evaluating the symptomatic patient

Investigation before any revision follows a structured pathway shared between gastroenterology and surgical teams. Upper endoscopy is mandatory and allows biopsy in those with persistent oesophagitis or Barrett's changes, an important consideration given the rising prevalence of Barrett's oesophagus documented in Australian cohorts. High-resolution manometry follows to exclude achalasia variants, ineffective motility, and distal spasm that may have been present but unrecognised at the original operation.

Ambulatory 24-hour pH or pH-impedance testing separates true acid reflux from functional heartburn and dysmotility-related symptoms that mimic reflux. A barium swallow complements these studies by demonstrating wrap position, oesophageal axis, and any residual herniation, particularly useful when the patient has already had multiple operations and surgical planes are likely scarred.

Medical and behavioural therapy

Not every recurrent symptom demands another operation. In the Australian context, where proton pump inhibitors are listed on the Pharmaceutical Benefits Scheme, a step-up in acid suppression, often to twice-daily dosing, controls symptoms in many patients. H2 receptor antagonists taken at night and alginate preparations after meals provide additional relief for those with non-acid or post-prandial symptoms.

Behavioural measures are reinforced at every review. Weight reduction, head-of-bed elevation, avoidance of late meals, and reduction of alcohol intake are supported by local dietetic services. Smoking cessation is encouraged through Quitline referrals, particularly relevant for reflux cohorts where tobacco compounds mucosal injury.

When revision is appropriate

The decision to operate again balances symptom severity against the morbidity of reoperative surgery. Strong indications include objectively confirmed recurrent acid reflux that fails medical therapy, para-oesophageal herniation with obstructive symptoms, and wrap-related complications such as stenosis or strangulation.

Relative indications include persistent regurgitation, volume reflux, and atypical symptoms that respond to acid suppression, where a demonstrable anatomical abnormality makes a mechanical solution plausible. Patients whose symptoms are functional, whose manometry shows a poorly contractile oesophagus, or whose expectations of post-operative swallowing are unrealistic, are better served by prolonged medical management rather than another operation.

Surgical options for the failed wrap

Revisional surgery is almost always laparoscopic, although conversion to an open or robotic approach is common in tertiary centres such as Royal Melbourne Hospital, Royal Prince Alfred, and Princess Alexandra in Brisbane. The default option remains a redo fundoplication with crural repair, using the same configuration as the index procedure when preoperative motility permits.

For patients with a short oesophagus, a Collis gastroplasty lengthens the intra-abdominal channel and reduces wrap tension. Magnetic sphincter augmentation with the LINX device has emerged as an attractive alternative in Australia for those with preserved peristalsis and a small hiatal defect. Where there is severe dysphagia, gross wrap disruption, or multiple prior revisions, conversion to a Roux-en-Y reconstruction provides definitive reflux control at the cost of altered gastrointestinal physiology.

Outcomes and local realities

Outcomes after revisional antireflux surgery are consistently inferior to those of primary repair, with higher rates of dysphagia, gas-bloat, and re-recurrence. Registry data from Australian and New Zealand centres reinforce this pattern, while also showing that surgeon volume and dedicated oesophageal units, concentrated in metropolitan centres, are associated with fewer complications and shorter length of stay.

For rural and remote patients, the barrier of distance makes preoperative work-up and postoperative review logistically harder. Telehealth follow-up, subsidised through Medicare, partly addresses this gap and is increasingly embedded in oesophageal surgical practice. Long-term endoscopic surveillance is recommended for anyone with Barrett's oesophagus or persistent symptoms after revision.

For clinicians managing these patients, the most productive next step is to refer candidates with recurrent symptoms to a regional oesophageal multidisciplinary meeting, where gastroenterology, surgery, radiology, and pathology can agree on the dominant mechanism and a unified plan before any reoperation is booked.